Career Development

职业发展

• 批准号: 9333239
• 负责人: ELLEN L. GOODE
• 金额: $ 4.98万
• 依托单位: MAYO CLINIC ROCHESTER
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-09-01 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/9333239
• 关键词: Achievement; Advisory Committees; Advocacy; Animal Model; Applications Grants; Area; Basic Science; Biometry; Biostatistics Core; Clinic; Clinical Sciences; Data; Development; Diagnosis; Disabled Persons; Disease; Eligibility Determination; Ensure; Environment; Extramural Activities; Faculty; Funding; Future; Goals; Grant; Individual; K-Series Research Career Programs; Leadership; Malignant neoplasm of ovary; Manuscripts; Medicine; Mentors; Mentorship; Minority; Monitor; Ovarian; Policies; Population Sciences; Prevention; Procedures; Process; Productivity; Program Development; Publishing; Recruitment Activity; Reporting; Research; Research Personnel; Resources; Scientist; System; Translational Research; Woman; Work; anticancer research; base; candidate selection; career; career development; expectation; improved; interest; meetings; multidisciplinary; programs; skills; success; translational scientist

ABSTRACT – Career Development Program The purpose of the Mayo Clinic SPORE in Ovarian Cancer is to stimulate, organize and facilitate rigorous translational research that will meaningfully reduce the burden of ovarian cancer. A critical part of this process is to increase the quality and depth of the translational investigator base in ovarian cancer. During the first five years of funding, four individuals received Career Development Awards and were supported with 1-2 years of funding, mentoring teams, and full access to SPORE resources. Our awardees have been highly successful, with 14 manuscripts published and an additional 2 under review, all receiving subsequent funding and two (Paul Haluska and Matthew Block) advancing to co-leadership of projects in this renewal application; additionally, Dr. Haluska is the Director of the Animal Models Core. All awardees relied upon the Biospecimens and Biostatistics Cores to develop their research programs; Dr. Haluska also partnered with the Animal Models Core. The ultimate objectives of the Career Development Program (CDP) continue to be the identification and mentoring of new and developing investigators in ovarian cancer who demonstrate clear potential to become independent translational researchers as well as attracting established scientists who wish to refocus on ovarian cancer. The CDP provides up to $100,000 for one year of support ($50,000 from SPORE funds and a matching $50,000 from Mayo Clinic); a second year is possible based on progress and continued translational trajectory. Emphasis is placed on attracting highly qualified individuals underrepresented in medicine, including women and minorities. Identifying and selecting CDP awardees is accomplished through a rigorous review process, followed by intense mentoring, integration into ongoing SPORE activities and close oversight of the individual's progress. In addition to a primary mentor, awardees have complementary mentors in clinical, basic or population sciences necessary to ensure development of a translational research career. This capitalizes on numerous strengths present within the Mayo environment. The CDP reports to the Executive Committee of the Mayo Clinic Ovarian Cancer SPORE. During the next funding period, the Ovarian SPORE will continue to maintain: (1) a stringent candidate selection system; (2) comprehensive trainee guidance by a primary mentor; (3) support through a scientific mentoring group (the Individual Trainee Mentorship Committee) comprised of investigators with expertise in each trainee`s area of interest; and (4) full integration into the SPORE, including access to all scientific Cores. Mayo Clinic provides an exceptional environment for developing careers in translational research in ovarian cancer. The CDP allows us to identify, mentor, and support young investigators who will become future leaders in ovarian cancer research.

摘要 – 职业发展计划 梅奥诊所 SPORE 治疗卵巢癌的目的是刺激、组织和促进严格的治疗 转化研究将有意义地减轻卵巢癌的负担。这个过程的关键部分 是为了提高卵巢癌转化研究基础的质量和深度。前五期间 经过多年的资助，四人获得了职业发展奖，并获得了 1-2 年的支持 资金、指导团队以及对 SPORE 资源的完全访问权。我们的获奖者非常成功， 已发表 14 篇手稿，另外 2 篇正在审查中，所有手稿均获得后续资助，另外 2 篇手稿已发表 （Paul Haluska 和 Matthew Block）在本次更新申请中晋升为项目的共同领导者； 此外，Haluska 博士是动物模型核心的主任。所有获奖者都依赖于 生物样本和生物统计核心开发他们的研究项目； Haluska 博士还与 动物模型核心。职业发展计划 (CDP) 的最终目标仍然是 识别和指导卵巢癌领域新的和正在发展的研究人员，这些研究人员表现出明确的 成为独立转化研究人员的潜力，并吸引希望的知名科学家 重新关注卵巢癌。 CDP 提供高达 100,000 美元的一年支持（其中 50,000 美元来自 SPORE 资金和 Mayo Clinic 提供的 50,000 美元配套资金）；根据进展情况，第二年是可能的 持续的平移轨迹。重点是吸引高素质人才 医学界的代表性不足，包括妇女和少数族裔。确定和选择 CDP 获奖者是 通过严格的审查过程，随后进行严格的指导，融入持续的过程中来完成 SPORE 活动并密切监督个人的进展。除了主要导师之外，获奖者 在临床、基础或人口科学方面拥有必要的补充导师，以确保发展 转化研究生涯。这利用了梅奥环境中存在的众多优势。 CDP 向 Mayo Clinic 卵巢癌 SPORE 执行委员会报告。在接下来的时间里 资助期间，Ovarian SPORE将继续保持：（1）严格的候选人筛选制度； (2) 由主要导师提供全面的实习生指导； (3) 科学指导小组的支持 个人实习生指导委员会）由在每个实习生领域具有专业知识的调查员组成 兴趣; (4) 完全融入 SPORE，包括访问所有科学核心。梅奥诊所提供 为卵巢癌转化研究事业的发展提供了优越的环境。中国民主党 使我们能够识别、指导和支持将成为卵巢癌未来领导者的年轻研究人员 研究。